BB Biotech

BB Biotech as of Dec. 31, 2012

Portfolio Holdings for BB Biotech

BB Biotech holds 19 positions in its portfolio as reported in the December 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Celgene Corporation 20.4 $210M 2.7M 78.47
Gilead Sciences (GILD) 14.3 $148M 2.0M 73.45
Vertex Pharmaceuticals Incorporated (VRTX) 8.3 $85M 2.0M 41.90
Incyte Corporation (INCY) 8.3 $85M 5.1M 16.61
ISIS Pharmaceuticals 8.2 $84M 8.0M 10.44
Ariad Pharmaceuticals 4.8 $50M 2.6M 19.18
Medivation 4.8 $49M 962k 51.16
ImmunoGen (IMGN) 4.4 $45M 3.6M 12.75
Alexion Pharmaceuticals 4.1 $42M 450k 93.74
Onyx Pharmaceuticals 4.0 $41M 547k 75.53
Medicines Company 3.7 $38M 1.6M 23.97
Halozyme Therapeutics (HALO) 3.6 $37M 5.6M 6.71
BioMarin Pharmaceutical (BMRN) 3.5 $36M 734k 49.20
Theravance 1.9 $20M 888k 22.24
Endocyte 1.8 $19M 2.1M 8.98
Achillion Pharmaceuticals 1.3 $14M 1.7M 8.01
Optimer Pharmaceuticals 1.3 $13M 1.4M 9.05
Dendreon Corporation 0.8 $8.1M 1.5M 5.29
Idenix Pharmaceuticals 0.6 $6.1M 1.3M 4.85